Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
Diseases of the Colon and Rectum
|
June 9, 2016
Development of The American Society of Colon and Rectal Surgeons' Rectal Cancer Surgery Checklist
Sean C Glasgow, Arden M Morris, Nancy N Baxter, et al.
Oncogene
|
September 13, 2016
Ecotropic viral integration site 1, a novel oncogene in prostate cancer
A Queisser, S Hagedorn, H Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2018
Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries
G Oskay-Özcelik, S Alavi, R Richter, et al.
Molecular Cancer Therapeutics
|
July 13, 2021
Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses <i>In Vivo</i>
Rocio Montes de Oca, Alireza S Alavi, Nick Vitali, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
Diseases of the Colon and Rectum
|
June 9, 2016
Development of The American Society of Colon and Rectal Surgeons' Rectal Cancer Surgery Checklist
Sean C Glasgow, Arden M Morris, Nancy N Baxter, et al.
Oncogene
|
September 13, 2016
Ecotropic viral integration site 1, a novel oncogene in prostate cancer
A Queisser, S Hagedorn, H Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 8, 2018
Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries
G Oskay-Özcelik, S Alavi, R Richter, et al.
Molecular Cancer Therapeutics
|
July 13, 2021
Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses <i>In Vivo</i>
Rocio Montes de Oca, Alireza S Alavi, Nick Vitali, et al.
Page
of 6